AU771901B2 - Methods and compositions for increasing intestinal absorption of fats - Google Patents

Methods and compositions for increasing intestinal absorption of fats Download PDF

Info

Publication number
AU771901B2
AU771901B2 AU57052/99A AU5705299A AU771901B2 AU 771901 B2 AU771901 B2 AU 771901B2 AU 57052/99 A AU57052/99 A AU 57052/99A AU 5705299 A AU5705299 A AU 5705299A AU 771901 B2 AU771901 B2 AU 771901B2
Authority
AU
Australia
Prior art keywords
fatty acid
lysophosphatidylcholine
monoglyceride
agent
isolated complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57052/99A
Other languages
English (en)
Other versions
AU5705299A (en
Inventor
David W. Yesair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomolecular Products Inc
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of AU5705299A publication Critical patent/AU5705299A/en
Application granted granted Critical
Publication of AU771901B2 publication Critical patent/AU771901B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU57052/99A 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats Ceased AU771901B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
US60/099430 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
AU5705299A AU5705299A (en) 2000-03-27
AU771901B2 true AU771901B2 (en) 2004-04-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57052/99A Ceased AU771901B2 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Country Status (13)

Country Link
US (1) US6426069B1 (cg-RX-API-DMAC10.html)
EP (1) EP1119360B1 (cg-RX-API-DMAC10.html)
JP (1) JP4700193B2 (cg-RX-API-DMAC10.html)
CN (1) CN1321089A (cg-RX-API-DMAC10.html)
AT (1) ATE347371T1 (cg-RX-API-DMAC10.html)
AU (1) AU771901B2 (cg-RX-API-DMAC10.html)
CA (1) CA2343116C (cg-RX-API-DMAC10.html)
DE (1) DE69934325T2 (cg-RX-API-DMAC10.html)
IL (2) IL141801A0 (cg-RX-API-DMAC10.html)
NO (1) NO20011173L (cg-RX-API-DMAC10.html)
NZ (1) NZ510536A (cg-RX-API-DMAC10.html)
WO (1) WO2000013689A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200102268B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434593B1 (en) * 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
ES2581184T3 (es) * 2003-01-31 2016-09-01 Childrens Hospital Los Angeles Composiciones orales de fenretinida que tienen mayor biodisponibilidad y métodos de uso de las mismas
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
CN103179990B (zh) * 2010-10-22 2015-02-04 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
CN118416114A (zh) * 2024-01-12 2024-08-02 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
EP0835097B1 (en) * 1995-06-06 2001-08-29 Biomolecular Products, Inc. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
NO20011173D0 (no) 2001-03-07
CA2343116A1 (en) 2000-03-16
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
JP4700193B2 (ja) 2011-06-15
WO2000013689A1 (en) 2000-03-16
EP1119360B1 (en) 2006-12-06
EP1119360A4 (en) 2003-06-04
DE69934325T2 (de) 2007-07-05
US6426069B1 (en) 2002-07-30
ATE347371T1 (de) 2006-12-15
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325D1 (de) 2007-01-18
NO20011173L (no) 2001-05-08
IL141801A (en) 2009-02-11
EP1119360A1 (en) 2001-08-01
CN1321089A (zh) 2001-11-07
ZA200102268B (en) 2001-09-19
CA2343116C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
US11998511B2 (en) Methods, compositions, and devices for supplying dietary fatty acid needs
CN100418519C (zh) 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
US6699496B1 (en) Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form
CA2343116C (en) Methods and compositions for increasing intestinal absorption of fats
KR20030016306A (ko) 지방산의 치료용 조합
JPH08193028A (ja) ヘリコバクターの阻害
KR20040004652A (ko) 조효소 q 및 에이코사펜타에노산(epa)
KR102830519B1 (ko) Lpc-dha 및 lpc-epa가 풍부한 크릴 오일 조성물
WO2008149177A2 (en) Marine lipid compositions and uses thereof
JPH08500332A (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
JP3467794B2 (ja) 学習能向上剤
US20080058286A1 (en) Novel applications of omega-3 rich phospholipids
CN1756544A (zh) 使超昼夜节律正常化的花生四烯酸的用途
CN119633026A (zh) 降血脂的制剂及藻类提取物在制备降血脂的制剂中的应用
WO2001049282A2 (en) Therapeutic preparations of highly unsaturated fatty acids
EP1106181A1 (en) Nutritional compositions for preventing or treating hyperlipoproteinemia
CN1345188A (zh) 含七碳脂肪酸甘油三酯的营养补充剂或药物制剂
US7842679B2 (en) Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
US20200085774A1 (en) Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
Chen et al. Docosahexaenoic acid-containing phospholipids and triglycerides based nutritional supplements
US20030032672A1 (en) Method for preparing a conjugated linoleic acid-containing structured lipid and use of the same
JPS62111926A (ja) コリン作働性神経系活性化剤
Staggers Lipid digestion and absorption in the suckling rat.
AU711302B2 (en) Nervonic acid compositions

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)